Error loading player: No playable sources found

  To view this video content in its entirety, click on the "Access Content" button and login to your account.

If you do not have an account, register for free.

Please note that the account you create here is different than your Keystone Symposia account at www.keystonesymposia.org used to register for our multi-day conferences and is uniquely for viewing our virtual content.


Leveraging Genomic Diversity to Promote Animal and Human Health

Free
Standard Price
This product is also available as part of the following products:


Genomic variation is a driving force in determining animal and human health and susceptibility to disease. Animal breeding has made huge strides in optimizing yield while lowering costs, and lessening the impact on the environment while also improving the general health of the animals. In human health there is a recent trend toward developing polygenic risk scores to stratify the population into disease risk categories. The clinical utility of genetic risk is dependent on the heritability of a trait and there is a keen awareness that many other factors, like the environment and behavior, influence individual risk. Predictions of health outcomes are therefore complicated and tests based on genetic variation lack specificity and sensitivity. The transferability across human populations remains uncertain, as most studies have been done on Europeans and some on Asians, but there is very little data from Africa. On the other hand, the environment and behavior of animals in an agricultural setting, can be better controlled and therefore genetic potential can be assessed at birth with much better predictive outcomes.

This thought-provoking ePanel broadcast will discuss a range of issues and questions, challenging current perceptions and thinking about future practices in human and animal health.

  • What are the limits to animal breeding using a genomic approach, if any?
  • How can we use the practices in animal breeding to think about public precision medicine?
  • Are concepts of “herd optimization” relevant to human health?
  • How does genetic diversity impact the transferability of knowledge from one population to another?
  • Are we sharing data in the human and animal fields in such a way that we can leverage it internationally to promote health?

Following the panel discussion broadcast, audience members watching the live event will be able to participate in a live Q&A with the panelists. Questions can be submitted during the broadcast via Twitter or the chat room, or in advance when registering for the event.



custom image

#VKSgenomicdiversity





In-kind support provided by:



custom image
custom image


custom image





This Keystone Symposia ePanel event was made possible by a grant from the Bill and Melinda Gates Foundation.


BMGF image





Video Previews






KS Insights: Leveraging Genomic Diversity to Promote Animal and Human Health






Moderator

Speaker Image for Michèle Ramsay
University of Witwatersrand

Panelists

Speaker Image for Han Brunner
Radboud Maastricht University Medical Center
Speaker Image for Michel Georges
University of Liège
Speaker Image for Appolinaire Djikeng
University of Edinburgh
Speaker Image for Vish Nene
International Livestock Research Institute

Related Products

Thumbnail for Accelerate to Equal: Engaging Women in Vector Control
Accelerate to Equal: Engaging Women in Vector Control
ACCELERATE TO EQUAL: ENGAGING WOMEN IN VECTOR CONTROL
Thumbnail for  Health Disparities: The Intersection of Science and Race
Health Disparities: The Intersection of Science and Race
Forty years ago, the infamous Tuskegee syphilis trials called attention to the disparate treatment of underrepresented (UR) populations in the U.S., prompting a major overhaul of the U.S. public healthcare system…
Thumbnail for Drug Discovery in Africa
Drug Discovery in Africa
_DRUG DISCOVERY RESEARCH IN AFRICA HAS LAGGED BEHIND THAT CARRIED OUT IN THE MORE DEVELOPED NATIONS OF THE WORLD._ Africa is often described as the “next frontier” in the global economy, yet a crippling disease burden continues to choke economic growth on the continent…
Thumbnail for Health Disparities: Sickle Cell, Research and CRISPR
Health Disparities: Sickle Cell, Research and CRISPR
About 100,000 people in the United States have sickle cell disease, with most of the patient population derived from communities of African descent…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.